Stability-Indicating and RP-HPLC Method for Analyzing Amlodipine Besylate in Commercially Available Drug Products in Kurdistan, Iraq
Abstract
This study aims to develop and validate a stability-indicating HPLC method for the simultaneous determination of Amlodipine (Amlo) in bulk and tablet dosage forms. The method’s goal is to evaluate the stability and degradation of Amlo under various stress conditions. The method was optimized using high-performance liquid chromatography (HPLC) with a UV detector. The mobile phase consisted of water and methanol in a 50:50 (v/v) ratio. An Eclipse XDB-C18 column (4.6 mm × 250 mm, 5 μm) was used for separation. The analysis was carried out at room temperature (25°C) with a 10 μL injection volume, a flow rate of 1.2 mL/min, and detection at 360 nm. Method validation was conducted in terms of linearity, precision, accuracy, limit of detection (LOD), and limit of quantification (LOQ). The stability of Amlodipine in tablet forms, under various stress conditions (acidic, alkaline, oxidative, thermal, and photolytic), was also evaluated. The finding showed excellent linearity (R² = 0.994) in the concentration range of 5–25 μg/mL. Precision was demonstrated by a relative standard deviation (RSD) of less than 0.8%. The LOD and LOQ were found to be 0.65 μg/mL and 2.16 μg/mL, respectively. Accuracy was assessed at three different levels, yielding recoveries above 98%. The method successfully detected the degradation products of Amlo under the applied stress conditions. The developed and validated HPLC method is simple, precise, and accurate for the simultaneous determination of Amlodipine in bulk and tablet forms. It is reliable for evaluating the stability and degradation of Amlo under different stress conditions, making it suitable for routine quality control and stability testing of Amlo-based pharmaceutical products.
Downloads
References
T. Semlitsch, C. Krenn, K. Jeitler, A. Berghold, K. Horvath and A. Siebenhofer. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database of Systematic Reviews, vol. 2021, no. 2, p. CD008274, 2021.
S. Tatar and S. Atmaca. Determination of amlodipine in human plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B: Biomedical Sciences and Applications, vol. 758, no. 2, pp. 305-310, 2001.
F. O. Qasim and N. M. S. Mohammed. A nanodrop spectrophotometric method and stability indicating for determination of amlodipine besylate in pharmaceutical formulations of Kurdistan of Iraq. Science Journal of University of Zakho, vol. 9, no. 1, pp. 25-29, 2021.
J. S. A. Shaikh, S. Raut, A. Abdul and M. A. A. K. Pathan. High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences., vol. 1155, p. 122295, 2020.
M. Attimarad, K. N. Venugopala, N. SreeHarsha, B. E. Aldhubiab and A. B. Nair. Validation of rapid RP-HPLC method for concurrent quantification of amlodipine and celecoxib in pure and formulation using an experimental design. Microchemical Journal, vol. 152, no. 3, p. 104365, 2020.
A. Mohammadi, N. Rezanour, M. Ansari Dogaheh, F. Ghorbani Bidkorbeh, M. Hashem and R. B. Walker. A stability-indicating High Performance Liquid Chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, vol. 846, no. 1-2, pp. 215-221, 2007.
A. K. Sarkar, D. Ghosh, A. Das, P. S. Selvan, K. V. Gowda, U. Mandal, A. Bose, S. Agarwal, U. Bhaumik and T. K. Pal. Simultaneous determination of metoprolol succinate and amlodipine besylate in human plasma by liquid chromatography-tandem mass spectrometry method and its application in bioequivalence study. Journal of
hromatography B, Analytical Technologies in the Biomedical and Life Sciences, vol. 873, no. 1, pp. 77-85, 2008.
H. Shamshad, A. Naz and A. Z. Mirza. Reverse Phase HPLC Method for the Simultaneous Determination of Cetirizine, verapamil/ Diltiazem and amlodipine. Analytical and Bioanalytical Chemistry Research, vol. 8, no. 2, pp. 139-145, 2020. https://doi.org/10.1007/BF03246509.
A. Darbandi, M. R. Sohrabi and M. Bahmaei. Development of a chemometric-assisted spectrophotometric method for quantitative simultaneous determination of amlodipine and valsartan in commercial tablet. Optik (Stuttg), vol. 218, p. 165110, 2020.
M. Sharma, C. Kothari, O. Sherikar and P. Mehta. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV-spectrophotometry. Journal of Chromatographic Science, vol. 52, no. 1, pp. 27-35, 2014.
D. Kushwaha, S. Diwakar, R. K. Roy, S. Karole, H. Kushwaha and P. Jain. Novel UV spectrophotometer methods for quantitative estimation of concensi (amlodipine 10mg and celecoxib 200mg) using hydrotropic solubilizing agents. Journal of Drug Delivery and Therapeutics, vol. 9, no. 4-A, pp. 651-655, 2019.
M. Attimarad, K. N. Venugopala, B. E. Aldhubiab, A. B. Nair, N. SreeHarsha, S. Pottathil and S. H. Akrawi. Development of UV spectrophotometric procedures for determination of amlodipine and celecoxib in formulation: Use of scaling factor to improve the sensitivity. Journal of Spectroscopy, vol. 2019, pp. 1-10, 2019.
A. P. Argekar and S. G. Powar. Simultaneous determination of atenolol and amlodipine in tablets by high-performance thinlayer chromatography. Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 6, pp. 1137-1142, 2000.
D. A. Shah, D. V. Patel, F. A. Mehta, U. K. Chhalotiya and K. K. Bhatt. High-performance thin-layer chromatography method for estimating the stability of a combination of irbesartan and amlodipine besylate. Journal of Taibah University for Science, vol. 9, no. 2, pp. 177-186, 2015.
J. Lukša, D. Josič, M. Kremser, Z. Kopitar and S. Milutinovič. Pharmacokinetic behaviour of R-(+)- and S-(-)- lodipine after single enantiomer administration. Journal of Chromatography B: Biomedical Sciences and Applications, vol. 703, no. 1-2, pp. 185-193, 1997.
A. M. Mahmoud, H. M. Abdel-Wadood and N. A. Mohamed. Kinetic spectrophotometric method for determination of amlodipine besylate in its pharmaceutical tablets. Journal of Pharmaceutical Analysis, vol. 2, no. 5, pp. 334-341, 2012.
B. Hemmateenejad, R. Miri and R. Kamali. A kinetic spectrophotometric method for determination of amlodipine and nifedipine in pharmaceutical preparations. Journal of the Iranian Chemical Society, vol. 6, no. 2, pp. 113-120, 2009.
S. Chakraborty, S. Sharmin, S. R. Rony, S. A. I. Ahmad and M. D. H. Sohrab. Stability-indicating UV/vis spectrophotometric method for diazepam, development and validation. Indian Journal of Pharmaceutical Sciences, vol. 80, no. 2, pp. 366-373, 2018.
F. O. Qasim, A. J. M. Ameen, K. M. Qadirc, M. A. Hamid and N. Yousif. A simple Stability-indicating UV spectrophotometric method developed and validation for detection of paracetamol in (liquid, solid) dosage form and biological fluid: Application and Comparison. Pakistan Journal of Life and Social Sciences, vol. 22, no. 2, pp. 2838- 50, 2024.
M. Blessy, R. D. Patel, P. N. Prajapati and Y. K. Agrawal. Development of forced degradation and stability indicating studies of drugs - A review. Journal of Pharmaceutical Analysis, vol. 4, no. 3, pp. 159-165, 2014.
F. O. Qasim, M. A. Hami and N. I. Yousif. developing and validating a stability-indicating UV-Vis nanodrop 2000c method for the simultaneous determination of the anti-hypertensive drug hydrochlorothiazide (HCTZ) in both bulk and tablet dosage forms. Science Journal of University of Zakho, vol. 12, no. 3, p. 375-381, 2024.
Copyright (c) 2024 Faroq O. Qasim, Nidhal M. Sher Mohammed, Nzar I. Yousif, Muhammed H. Fattah
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License [CC BY-NC-ND 4.0] that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
